drugset / Trial / NCT00905346

Topiramate 25 mg Capsule Mixed With Applesauce Under Fasting Conditions

NCT00905346

Phase 1 Completed 24 enrolled Teva Pharmaceuticals USA
RandomizedCrossoverOpen-labelOther

Summary

The objective of this study was to compare the rate and extent of absorption or topiramate 25 mg capsules (test) versus Topamax® (reference) administered as the content of 2 x 25 mg capsules mixed with applesauce under fasting conditions.

Timeline

Start
2002-06
Primary completion
2002-07
Completion
2002-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Topiramate Small molecule 50 mg

Indications

No indication recorded.